Cargando…
Microarray analysis of the in vivo sequence preferences of a minor groove binding drug
BACKGROUND: Minor groove binding drugs (MGBDs) interact with DNA in a sequence-specific manner and can cause changes in gene expression at the level of transcription. They serve as valuable models for protein interactions with DNA and form an important class of antitumor, antiviral, antitrypanosomal...
Autores principales: | Eckdahl, Todd T, Brown, Adam D, Hart, Steven N, Malloy, Kelly J, Shott, Martha, Yiu, Gloria, Hoopes, Laura L Mays, Heyer, Laurie J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2254601/ https://www.ncbi.nlm.nih.gov/pubmed/18215295 http://dx.doi.org/10.1186/1471-2164-9-32 |
Ejemplares similares
-
HIV chromatin is a preferred target for drugs that bind in the DNA minor groove
por: Collings, Clayton K., et al.
Publicado: (2019) -
Providing Structure for Research Students Coming and Going
por: Campbell, A. Malcolm, et al.
Publicado: (2012) -
Conditional Cooperativity in DNA Minor-Groove Recognition by Oligopeptides
por: Lah, Jurij, et al.
Publicado: (2021) -
Mismatch repair deficiency is associated with resistance to DNA minor groove alkylating agents
por: Colella, G, et al.
Publicado: (1999) -
Syntheses and characterizations of the in vivo replicative bypass and mutagenic properties of the minor-groove O(2)-alkylthymidine lesions
por: Zhai, Qianqian, et al.
Publicado: (2014)